PCM
BLFS icon

Peregrine Capital Management’s BioLife Solutions BLFS Stock Holding History

Peregrine Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.19M Sell
325,382
-16,465
-5% -$385K 0.3% 99
2026
Q1 		$6.52M Sell
341,847
-14,496
-4% -$320K 0.24% 124
2025
Q4 		$8.62M Sell
356,343
-4,799
-1% -$126K 0.26% 106
2025
Q3 		$9.21M Sell
361,142
-9,521
-3% -$226K 0.28% 96
2025
Q2 		$7.98M Buy
370,663
+6,217
+2% +$140K 0.24% 116
2025
Q1 		$8.32M Buy
364,446
+12,241
+3% +$322K 0.28% 96
2024
Q4 		$9.14M Buy
352,205
+54,100
+18% +$1.35M 0.27% 90
2024
Q3 		$7.46M Buy
298,105
+649
+0.2% +$15.3K 0.23% 116
2024
Q2 		$6.37M Buy
297,456
+3,869
+1% +$75.1K 0.19% 192
2024
Q1 		$5.45M Buy
293,587
+100
+0% +$1.75K 0.16% 228
2023
Q4 		$4.77M Sell
293,487
-50,663
-15% -$646K 0.14% 232
2023
Q3 		$4.75M Sell
344,150
-21,611
-6% -$341K 0.14% 234
2023
Q2 		$8.08M Sell
365,761
-113
-0% -$2.38K 0.22% 192
2023
Q1 		$7.96M Buy
365,874
+80,226
+28% +$1.8M 0.23% 193
2022
Q4 		$5.2M Sell
285,648
-8,646
-3% -$179K 0.16% 231
2022
Q3 		$6.7M Sell
294,294
-16,276
-5% -$348K 0.22% 210
2022
Q2 		$4.29M Sell
310,570
-232
-0.1% -$3.4K 0.13% 245
2022
Q1 		$7.07M Sell
310,802
-22,277
-7% -$586K 0.17% 230
2021
Q4 		$12.4M Buy
+333,079
New +$14.3M 0.25% 144

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Peregrine Capital Management's BLFS Position: Q2 2026 in Review

Peregrine Capital Management reduced its BioLife Solutions (BLFS) stake by 4.8% in Q2 2026, selling an estimated $385K and leaving 325,382 shares worth $9.19M. The position accounts for 0.3% of the portfolio, ranked #99.

Peregrine Capital Management first reported a position in BLFS in Q4 2021 and has held it in 19 quarters since. The position peaked at $12.4M in Q4 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Peregrine Capital Management held 325,382 shares of BioLife Solutions worth $9.19M as of Q2 2026.
  • Peregrine Capital Management sold 16,465 BioLife Solutions shares in Q2 2026, an estimated $385K.
  • BioLife Solutions made up 0.3% of Peregrine Capital Management's portfolio in Q2 2026, its #99 holding.
  • Peregrine Capital Management first reported a position in BioLife Solutions in Q4 2021 and has held it in 19 quarters since.
  • Peregrine Capital Management's BioLife Solutions position peaked at $12.4M in Q4 2021.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.